PT Pyridam Farma Tbk Share Price

Equities

PYFA

ID1000075609

Pharmaceuticals

End-of-day quote INDONESIA S.E. 23:00:00 21/05/2024 BST 5-day change 1st Jan Change
123 IDR +6.03% Intraday chart for PT Pyridam Farma Tbk +18.27% -89.26%

Financials

Sales 2022 715B 45.07M 3.52B Sales 2023 702B 44.23M 3.45B Capitalization 613B 38.6M 3.01B
Net income 2022 275B 17.35M 1.35B Net income 2023 -85.22B -5.37M -419M EV / Sales 2022 1.73 x
Net Debt 2022 773B 48.73M 3.8B Net Debt 2023 897B 56.51M 4.41B EV / Sales 2023 2.15 x
P/E ratio 2022
1.68 x
P/E ratio 2023
-7.19 x
Employees 1,193
Yield 2022 *
-
Yield 2023
-
Free-Float 36.08%
More Fundamentals * Assessed data
Dynamic Chart
Foreign Investment Review Board Clears Probiotec Acquisition by Pyridam Farma MT
PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Probiotec Enters Scheme Implementation Bid With Indonesia-Listed Pyridam Farma MT
PT Pyridam Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
PT Pyridam Farma Tbk Reports Earnings Results for the Half Year Ended June 30, 2023 CI
PT Pyridam Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Pharmanutra S.P.A. Announces New Distribution Agreements in Indonesia, Kuwait and Mexico CI
PT Pyridam Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
PT Pyridam Farma Tbk Reports Earnings Results for the Half Year Ended June 30, 2022 CI
PT Pyridam Farma Tbk and PT Pyfa Sehat Indonesia entered into an agreement to acquire PT. ETHICA Industri Farmasi from Fresenius Kabi Aktiengesellschaft and Fresenius Kabi Deutschland Gmbh for IDR 163.4 billion. CI
PT Pyridam Farma Tbk Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
PT Pyridam Farma Tbk Reports Earnings Results for the Full Year Ended December 31, 2021 CI
PT Pyridam Farma Tbk and PT Pyfa Sehat Indonesia completed the acquisition of PT Holi Pharma from Erik Darius Mardiwidyo and Murtiation for IDR 108 billion. CI
PT Pyridam Farma Tbk Reports Earnings Results for the Nine Months Ended September 30, 2021 CI
More news
1 day+6.03%
1 week+18.27%
Current month+19.42%
1 month+16.04%
3 months-83.60%
6 months-84.23%
Current year-89.26%
More quotes
1 week
104.00
Extreme 104
127.00
1 month
81.00
Extreme 81
127.00
Current year
81.00
Extreme 81
1 545.00
1 year
81.00
Extreme 81
1 545.00
3 years
81.00
Extreme 81
1 545.00
5 years
81.00
Extreme 81
1 640.00
10 years
81.00
Extreme 81
1 640.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 61 13/08/20
Director of Finance/CFO 38 13/08/20
Corporate Officer/Principal 60 21/06/23
Members of the board TitleAgeSince
Director/Board Member 71 24/05/15
Chairman 42 13/08/20
Director/Board Member 65 09/03/22
More insiders
Date Price Change Volume
22/05/24 123 +6.03% 279,576,200
21/05/24 116 +3.57% 182,049,300
20/05/24 112 +7.69% 141,961,400
17/05/24 104 -0.95% 35,003,100

End-of-day quote INDONESIA S.E., May 21, 2024

More quotes
PT Pyridam Farma Tbk is an Indonesia-based pharmaceutical company. The Company is engaged in the production, development, and trade of pharmaceuticals, as well as the trade of medical devices and cosmetics. Its segments include pharmaceutical products, esthetic, and toll manufacturing services; and medical equipments. It offers products across consumer health, pyfaesthetic, sanitizer and antiseptic, sterile/injection, biomedilab, betadine group and guardix, and medical support categories. The consumer health category provides over the counter drugs, including supplements and other preventive products, along with energy drinks and healthy ready-to-drink products. Its pyfaesthetic category includes products, such as Arosa Gel, A-Stark Gel, Hymen Gel, Pyderen Emulsion, Tonic Bust Emulsion, Calmosan Cream, and Di-Herb Gel. Its sterile/injection category is focused on injection products. Its biomedilab category provides various medical equipment and tools for hospital laboratories.
More about the company